Do you want to read an article? Please log in or register.
Redefining the risk of major arrhythmic events in non-ischaemic cardiomyopathy: insights from the DERIVATE-NICM study
Heart, Artery and Coronary Diseases
Related content
Heart Failure
Mortality risk following ischaemic and non-ischaemic heart failure in people with type 2 diabetes: Observational study in England, 2000-2021
Diabetes Obes Metab
Panchal K, Lawson CA, Shabnam S, Khunti K, Zaccardi F
doi: 10.1111/dom.16413
Cardiovascular Risk and Diseases
Improved prediction and risk stratification of major adverse cardiovascular events using an explainable machine learning approach combining plasma biomarkers and traditional risk factors
Cardiovasc Diabetol
Zhang XR, Zhong WF, Liu RY, Huang JL, Fu JX, Gao J, Zhang PD, Liu D, Li ZH, He Y, Zhou H, Li Z
doi: 10.1186/s12933-025-02711-x
Cardiac Arrest or Death
Association between programmed electrical stimulation inducibility and arrhythmic risk in hypertrophic cardiomyopathy: a systematic review and meta-analysis
Heart
Salihu A, Antiochos P, Lu H, Maurizi N, Monney P, Pascale P
doi: 10.1136/heartjnl-2024-325043
Cardiovascular Risk and DiseasesTherapy and Intervention
Fibrin clot strength is associated with increased risk of major adverse cardiac events after TAVR
Clin Res Cardiol
Hesselbarth D, D'Orazio M, Ciccarone G, Gjermeni D, Jülch C, Wessinger M, Maslarska M, Rilinger J, Hilgendorf I, Wolf D, Kaier K, Duerschmied D, Pottgiesser T, von Zur Mühlen C, Westermann D, Olivier CB
doi: 10.1007/s00392-025-02749-7
COMMENTED
Cardiovascular Risk and Diseases
Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol
Patsoukaki V, Lind L, Lampa E, Radhi S, Eeg-Olofsson K, Eliasson B, Eriksson JW
doi: 10.1016/S2213-8587(25)00165-2
Heart, Artery and Coronary Diseases
A Metabolomics Study of Cardiac Dysfunction in Hyperglycemia-Findings From the Atherosclerosis Risk in Communities (ARIC) Study and the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
Diabetes Care
Yoshida Y, Nguyen NQ, Moon EH, Rebholz C, Skali H, Arthur V, Echouffo-Tcheugui JB, Ballantyne C, Selvin E, Shah A, Kaplan R, Rodriguez CJ, Qi Q, Cheng S, Yu B
doi: 10.2337/dc25-0730
Cardiovascular Risk and Diseases
Risk acceleration by gout on major adverse cardiovascular events and all-cause death in patients with diabetes and chronic kidney disease
Diabetes Obes Metab
Lee DY, Moon JS, Jung I, Chung SM, Park SY, Yu JH, Seo JA, Han KD, Kim NH
doi: 10.1111/dom.16165
RECOMMENDED
Heart Failure
Lipoprotein(a) and Heart Failure Among Black and White Participants in Atherosclerosis Risk in Communities Study, Framingham Offspring Study, and Multi-Ethnic Study of Atherosclerosis: The Pooling Project
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
J Am Heart Assoc
Nomura S, Guan W, Zhang Y, Tison GH, Ikezaki H, Diffenderfer MR, Liu CT, Hoogeveen RC, Ballantyne CM, Schaefer EJ, Tsai MY
doi: 10.1161/JAHA.124.038608
Cardiovascular Risk and Diseases
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
Lancet Diabetes Endocrinol
Aggarwal R, Bhatt DL, Szarek M, Cannon CP, Leiter LA, Inzucchi SE, Lopes RD, McGuire DK, Lewis JB, Riddle MC, Davies MJ, Banks P, Carroll AK, Scirica BM, Ray KK, Kosiborod MN, Cherney DZI, Udell JA, Verma S, Mason RP, Pitt B, Steg PG
doi: 10.1016/S2213-8587(24)00362-0